Japan Plans Replicon Vaccine Rollout Despite Unknown Shedding Risk

Japanese Dr. Miki Gibo expresses concerns about Replicon mRNA vaccines that will be launching this fall.

Starting this fall, the replicon vaccine is planned to be administered to the elderly, But there is a concern that it might spread even to the unvaccinated. Let's take a look at a paper published in the leading medical journal, Cell. It's an experiment where a substance similar to the replicon vaccine was replicated and ingested by cells. After 24 hours, the vaccine components were observed to be increasing in cells.

Next, what happens if when the supernatant liquid of these cells is sprinkled onto new cells The vaccine components continue to spread to new cells transferring to new cells.

Why is this happening?

The cells that initially ingested the vaccine components continuously excrete cellular fragments known as extracellular vesicles (the smaller ones are called exosomes). The supernatant contains many such extracellular vesicles, which facilitates the spread of the infection to new cells.

In humans, it's known that body fluids like tears, nasal discharge, saliva, and sweat contain many of these exosomes.

Therefore, there is a concern that the vaccine components might spread to the unvaccinated through body fluids.

Pharmaceutical companies need to properly verify whether it spreads to others before releasing it to the public.

Please explain this to ensure that elderly people don't unintentionally expose themselves.

VIDEO AND TEXT SOURCE: https://x.com/_aussie17/status/1830786982039167198